Prevalence of Cachexia in Patients Undergoing Chemotherapy
- Conditions
- CachexiaCancer
- Registration Number
- NCT01939340
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
Cachexia and low nutritional intake are a common phenomena in cancer patients undergoing chemotherapy. The purpose of this study is to assess prevalence of cachexia and low nutritional intake and the impact on quality of life, fatigue and mortality in patients undergoing chemotherapy. Furthermore interactions between these parameters, tumor disease and chemotherapy, respectively.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 285
- Patients undergoing chemotherapy at least in the second cycle.
- Patients who have signed a written Informed Consent.
- Patients with implanted pacemaker or defibrillator.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Nutritional intake 1 day Nutritional intake will be assessed by 24h-recall, which will be analysed with regard to macronutritients
- Secondary Outcome Measures
Name Time Method Mortality 6 months Mortality will be assesses via telephone or consultation of the local death register
Quality of life and fatigue 1 day EORTC QLQ C-30 will be used to assess quality of life and additionally cancer-related fatigue will be evaluated using Brief Fatigue Inventory.
Cachexia 1 day Cachexia will be evaluated using the patient-generated Subjective Global Assessment.
Trial Locations
- Locations (1)
Dept. of Gastroenterology, Infectiology and Rheumatology (including workspace nutrition medicine), Charité Universitätsmedizin Berlin
🇩🇪Berlin, Germany